Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A

PURPOSE: To assess the impact of botulinum toxin type A (BTX-A) on signs and symptoms of dry eye (DE) in affected eye of hemifacial spasm (HFS) patients and to compare the prevalence of DE between affected and non-affected eye in HFS patients. PATIENTS AND METHODS: This prospective study included pa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Ophthalmol
Asıl Yazarlar: Jariyakosol, Supharat, Uthaithammarat, Lita, Chatwichaikul, Nattakarn, Kasetsuwan, Ngamjit, Chongpison, Yuda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090983/
https://ncbi.nlm.nih.gov/pubmed/33953536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S305817
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller